Breslin Cancer Center — Lansing, Michigan

Breslin Cancer Center is a clinical research site located in Lansing, Michigan, United States 48910.

Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.

Breslin Cancer Center has participated in 6 clinical trials with 1 currently active.

Therapeutic areas: Breast Cancer, Advanced Solid Tumor, Breast Neoplasms.

Sponsors: Michigan State University, EMD Serono Research & Development Institute, Inc., Eli Lilly and Company.

Sponsor Feasibility Report

Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Breslin Cancer Center?

Breslin Cancer Center has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Breslin Cancer Center conducted?

Breslin Cancer Center has 6 clinical trials on record, with 1 currently active. Their work covers Breast Cancer, Advanced Solid Tumor, Breast Neoplasms.

Is Breslin Cancer Center accredited by Crixeo Health?

Yes — Breslin Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Breslin Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.